Ellevest, Inc. Savara Inc Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$1.18 - $1.64 $119 - $165	-101 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$1.0 - $1.47 $771 - $1,133	-771 Reduced 88.42%	101 $0
Q3 2020 Oct 26, 2020	BUY	$1.09 - $2.21 $950 - $1,927	872 New	872 $1,000
Q2 2020 Jul 06, 2020	SELL	$1.8 - $3.05 $955 - $1,619	-531 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$1.91 - $4.08 $11 - $24	6 Added 1.14%	531 $1,000
Q4 2019 Feb 05, 2020	BUY	$0.71 - $4.91 $372 - $2,577	525 New	525 $2,000

128

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.